Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination
May 30, 2024 16:00 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), announced today that on May 23, 2024, it received written notice (the...
Connexa Announces Receipt of Nasdaq Delisting Notice
February 21, 2023 08:30 ET
|
Connexa Sports Technologies Inc.
Baltimore, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Connexa Sports Technologies Inc. (NASDAQ: CNXA) (www.connexasports.com) (the “Company”) announced that it received a letter from The Nasdaq Stock...